- Home
- CBAT vs OKUR Comparison
CBAT vs OKUR Comparison
Compare CBAT & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- OKUR
- Stock Information
- Founded
- CBAT 1999
- OKUR 2011
- Country
- CBAT China
- OKUR United States
- Employees
- CBAT N/A
- OKUR N/A
- Industry
- CBAT Industrial Machinery/Components
- OKUR
- Sector
- CBAT Miscellaneous
- OKUR
- Exchange
- CBAT Nasdaq
- OKUR NYSE
- Market Cap
- CBAT 83.0M
- OKUR 76.6M
- IPO Year
- CBAT N/A
- OKUR N/A
- Fundamental
- Price
- CBAT $0.86
- OKUR $5.46
- Analyst Decision
- CBAT
- OKUR Strong Buy
- Analyst Count
- CBAT 0
- OKUR 4
- Target Price
- CBAT N/A
- OKUR $35.00
- AVG Volume (30 Days)
- CBAT 197.4K
- OKUR 71.3K
- Earning Date
- CBAT 03-14-2025
- OKUR 03-04-2025
- Dividend Yield
- CBAT N/A
- OKUR N/A
- EPS Growth
- CBAT N/A
- OKUR N/A
- EPS
- CBAT 0.12
- OKUR N/A
- Revenue
- CBAT $207,423,403.00
- OKUR N/A
- Revenue This Year
- CBAT $0.46
- OKUR N/A
- Revenue Next Year
- CBAT $13.78
- OKUR N/A
- P/E Ratio
- CBAT $7.12
- OKUR N/A
- Revenue Growth
- CBAT 2.32
- OKUR N/A
- 52 Week Low
- CBAT $0.77
- OKUR $4.58
- 52 Week High
- CBAT $2.08
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- CBAT 41.36
- OKUR N/A
- Support Level
- CBAT $0.85
- OKUR N/A
- Resistance Level
- CBAT $0.92
- OKUR N/A
- Average True Range (ATR)
- CBAT 0.04
- OKUR 0.00
- MACD
- CBAT -0.00
- OKUR 0.00
- Stochastic Oscillator
- CBAT 10.00
- OKUR 0.00
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization and distribution of a variety of standard and customized lithium-ion high-power rechargeable batteries. The company operates in two operating segments: CBAK's segment mainly includes the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion rechargeable batteries for use in a wide array of applications. Hitrans' segment mainly includes the development and manufacturing of NCM precursor and cathode materials. Geographically, it generates a majority of its revenue from Mainland China and also has an operation in Europe, the United States, Korea, and Other Countries.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.